# OnCo record paper-liedtke-neoadjuvant-response-survival-tnbc-jco-2008 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-liedtke-neoadjuvant-response-survival-tnbc-jco-2008/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-liedtke-neoadjuvant-response-survival-tnbc-jco-2008" ;
  schema:name "Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer"@en ;
  schema:description "The 2008 MD Anderson series of 1,118 women that defined the triple-negative paradox: these tumours disappear completely with pre-surgery chemotherapy twice as often as other breast cancers, yet survival is worse, because the women left with residual disease relapse early and often."@en ;
  schema:url <https://onco.cc/key-papers/paper-liedtke-neoadjuvant-response-survival-tnbc-jco-2008/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2007.14.4147>, <https://pubmed.ncbi.nlm.nih.gov/18250347/> ;
  onco:tag "tnbc-evidence" ;
  schema:sameAs <https://doi.org/10.1200/JCO.2007.14.4147> ;
  schema:datePublished "2008"^^xsd:gYear ;
  schema:author "Liedtke C, Mazouni C, Hess KR, et al." ;
  onco:related <https://onco.cc/key-papers/paper-symmans-j-clin-oncol/>, <https://onco.cc/key-papers/paper-cortazar-ctneobc-pcr-pooled-analysis-lancet-2014/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> ;
  onco:terms <https://onco.cc/terms/pcr/>, <https://onco.cc/terms/rcb/>, <https://onco.cc/terms/neoadjuvant-adjuvant/> ;
  onco:journals <https://onco.cc/journals/jco/> .